(pharmacology) An anthracycline antibiotic drug (trademark Adriamycin) with broad antineoplastic activity that is obtained from a bacterium (Streptomyces peucetius subsp. caesius) and is administered in the form of its hydrochloride C₂₇H₂₉NO₁₁·HCl in chemotherapy.
